Matches in Wikidata for { <http://www.wikidata.org/entity/Q91701226> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91701226 description "articolo scientifico (pubblicato il 2020)" @default.
- Q91701226 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q91701226 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q91701226 description "scientific article published on 01 February 2020" @default.
- Q91701226 description "wetenschappelijk artikel" @default.
- Q91701226 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q91701226 name "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 name "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 type Item @default.
- Q91701226 label "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 label "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 prefLabel "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 prefLabel "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 P1433 Q91701226-C1AB8F98-7C1C-4451-BACB-0DB68AAF07C9 @default.
- Q91701226 P1476 Q91701226-6467A6C8-8BA4-484D-A68C-A9561517CB94 @default.
- Q91701226 P2093 Q91701226-9D2D0CFA-B7E8-48CE-9774-7DD5AD66981C @default.
- Q91701226 P2093 Q91701226-AA2E435B-4DCD-41C0-8EC0-C5862F89B59E @default.
- Q91701226 P2093 Q91701226-BBECDDA9-FA7E-4DC9-A7A0-3157E97A708D @default.
- Q91701226 P2093 Q91701226-CB593BB0-6C19-4BFA-AB1B-617CD9880F40 @default.
- Q91701226 P2860 Q91701226-51D2B07D-B9D4-418D-9007-E32B2EE4F9A8 @default.
- Q91701226 P2860 Q91701226-54C1A2A7-D10C-4252-8421-AA4145E16B45 @default.
- Q91701226 P2860 Q91701226-774543BA-C750-4CD5-9600-C5882044EB68 @default.
- Q91701226 P2860 Q91701226-84DEE456-F6A7-4C58-9F35-E9025E6B805B @default.
- Q91701226 P2860 Q91701226-93841D37-3FCD-408E-8BFD-DF3A8E232EFD @default.
- Q91701226 P2860 Q91701226-A4F50EC7-04C7-4C51-9254-69380E87DD8F @default.
- Q91701226 P2860 Q91701226-DCA38DF3-B355-4E28-9136-0469132667ED @default.
- Q91701226 P2860 Q91701226-F10DB2A9-BFBD-46AD-8553-B1EA04C16AF3 @default.
- Q91701226 P304 Q91701226-95E6FFDA-A5C3-4940-AC17-46C977236718 @default.
- Q91701226 P31 Q91701226-4ACF6D62-F7ED-48AE-86E6-ACB734543A04 @default.
- Q91701226 P356 Q91701226-53B5CA3C-3074-4A9D-8083-152B1AD11537 @default.
- Q91701226 P433 Q91701226-F16E099C-A02F-4322-8638-9182AC6EE276 @default.
- Q91701226 P478 Q91701226-C9F61A53-DDA8-49C2-A539-E78F8BA2C420 @default.
- Q91701226 P50 Q91701226-5A1E215F-92CE-45A8-8988-A3F2DCD3D161 @default.
- Q91701226 P50 Q91701226-BAA4C734-4972-4562-9718-F85EB89A45CB @default.
- Q91701226 P50 Q91701226-FB946B59-DBD1-4526-8C91-8EF5337711FE @default.
- Q91701226 P577 Q91701226-7E09A130-5961-4839-9388-418FB15F22EC @default.
- Q91701226 P698 Q91701226-D367CA83-DF6B-4447-9F97-C4FC3A0D55C1 @default.
- Q91701226 P932 Q91701226-BF13D066-A817-4C2D-A6D2-BD5D21B0B84D @default.
- Q91701226 P356 S40262-019-00848-Z @default.
- Q91701226 P698 31802401 @default.
- Q91701226 P1433 Q5133788 @default.
- Q91701226 P1476 "Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"" @default.
- Q91701226 P2093 "A A Ferran" @default.
- Q91701226 P2093 "J L Montastruc" @default.
- Q91701226 P2093 "P Gandia" @default.
- Q91701226 P2093 "P Lees" @default.
- Q91701226 P2860 Q37673233 @default.
- Q91701226 P2860 Q47114415 @default.
- Q91701226 P2860 Q51776984 @default.
- Q91701226 P2860 Q73082576 @default.
- Q91701226 P2860 Q91427971 @default.
- Q91701226 P2860 Q92506774 @default.
- Q91701226 P2860 Q92740204 @default.
- Q91701226 P2860 Q95588277 @default.
- Q91701226 P304 "269-271" @default.
- Q91701226 P31 Q13442814 @default.
- Q91701226 P356 "10.1007/S40262-019-00848-Z" @default.
- Q91701226 P433 "2" @default.
- Q91701226 P478 "59" @default.
- Q91701226 P50 Q59679382 @default.
- Q91701226 P50 Q86529470 @default.
- Q91701226 P50 Q89599789 @default.
- Q91701226 P577 "2020-02-01T00:00:00Z" @default.
- Q91701226 P698 "31802401" @default.
- Q91701226 P932 "7007435" @default.